APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Disease Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Autoimmune Disease Drug Industry Growth and Trends Forecast to 2032

Report ID 17396836012 January 2026103 pages

Choose your research edition.

Industry ResearchAutoimmune Disease Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Disease Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Autoimmune Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Disease Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Disease Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Autoimmune Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Autoimmune Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Autoimmune Disease Drug market include Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Amgen, AbbVie, Bristol-Myers Squibb, Biogen and AstraZeneca plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Autoimmune Disease Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Autoimmune Disease Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Autoimmune Disease Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Autoimmune Disease Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Autoimmune Disease Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Autoimmune Disease Drug Market by Company

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Amgen

AbbVie

Bristol-Myers Squibb

Biogen

AstraZeneca plc

Abbott Laboratories

Autoimmune Disease Drug Segment by Type

NSAIDs

Interferons

Antihyperglycemics

Anti-Inflammatory

Others

Autoimmune Disease Drug Segment by Application

Psoriasis

Inflammatory Bowel Disease

Rheumatoid Arthritis

Lupus

Multiple Sclerosis

Type 1 Diabetes

Others

Autoimmune Disease Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Autoimmune Disease Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Autoimmune Disease Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Autoimmune Disease Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Autoimmune Disease Drug Market Share by Region (2021-2026) Table 4. Global Autoimmune Disease Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Autoimmune Disease Drug Market Share by Region (2027-2032) Table 6. Global Autoimmune Disease Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Autoimmune Disease Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Autoimmune Disease Drug Market Size Share by Type (2021-2026) Table 9. Global Autoimmune Disease Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Autoimmune Disease Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Autoimmune Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Autoimmune Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Autoimmune Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Autoimmune Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Autoimmune Disease Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Autoimmune Disease Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Autoimmune Disease Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Autoimmune Disease Drug Market Size Share by Application (2021-2026) Table 24. Global Autoimmune Disease Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Autoimmune Disease Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Autoimmune Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Autoimmune Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Autoimmune Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Autoimmune Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Autoimmune Disease Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Autoimmune Disease Drug Industry Trends Table 37. Autoimmune Disease Drug Industry Drivers Table 38. Autoimmune Disease Drug Industry Opportunities and Challenges Table 39. Autoimmune Disease Drug Industry Restraints Table 40. Global Autoimmune Disease Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Autoimmune Disease Drug Revenue Market Share by Company (2021-2026) Table 42. Global Autoimmune Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Autoimmune Disease Drug Key Company Headquarters & Area Served Table 44. Global Autoimmune Disease Drug Company, Product Type & Application Table 45. Global Autoimmune Disease Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Autoimmune Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Roche Autoimmune Disease Drug Product Portfolio Table 52. Roche Recent Development Table 53. Eli Lilly Company Information Table 54. Eli Lilly Business Overview Table 55. Eli Lilly Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eli Lilly Autoimmune Disease Drug Product Portfolio Table 57. Eli Lilly Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pfizer Autoimmune Disease Drug Product Portfolio Table 62. Pfizer Recent Development Table 63. GlaxoSmithKline Company Information Table 64. GlaxoSmithKline Business Overview Table 65. GlaxoSmithKline Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. GlaxoSmithKline Autoimmune Disease Drug Product Portfolio Table 67. GlaxoSmithKline Recent Development Table 68. Amgen Company Information Table 69. Amgen Business Overview Table 70. Amgen Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Amgen Autoimmune Disease Drug Product Portfolio Table 72. Amgen Recent Development Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AbbVie Autoimmune Disease Drug Product Portfolio Table 77. AbbVie Recent Development Table 78. Bristol-Myers Squibb Company Information Table 79. Bristol-Myers Squibb Business Overview Table 80. Bristol-Myers Squibb Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Autoimmune Disease Drug Product Portfolio Table 82. Bristol-Myers Squibb Recent Development Table 83. Biogen Company Information Table 84. Biogen Business Overview Table 85. Biogen Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biogen Autoimmune Disease Drug Product Portfolio Table 87. Biogen Recent Development Table 88. AstraZeneca plc Company Information Table 89. AstraZeneca plc Business Overview Table 90. AstraZeneca plc Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AstraZeneca plc Autoimmune Disease Drug Product Portfolio Table 92. AstraZeneca plc Recent Development Table 93. Abbott Laboratories Company Information Table 94. Abbott Laboratories Business Overview Table 95. Abbott Laboratories Autoimmune Disease Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Abbott Laboratories Autoimmune Disease Drug Product Portfolio Table 97. Abbott Laboratories Recent Development Table 98. North America Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Autoimmune Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Autoimmune Disease Drug Market Share by Country (2021-2026) Table 101. North America Autoimmune Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Autoimmune Disease Drug Market Share Forecast by Country (2027-2032) Table 103. Europe Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Autoimmune Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Autoimmune Disease Drug Market Share by Country (2021-2026) Table 106. Europe Autoimmune Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Autoimmune Disease Drug Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Autoimmune Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Autoimmune Disease Drug Market Share by Country (2021-2026) Table 111. Asia-Pacific Autoimmune Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Autoimmune Disease Drug Market Share Forecast by Country (2027-2032) Table 113. Latin America Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Autoimmune Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Autoimmune Disease Drug Market Share by Country (2021-2026) Table 116. Latin America Autoimmune Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Autoimmune Disease Drug Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2021-2026) Table 121. Middle East & Africa Autoimmune Disease Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Autoimmune Disease Drug Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Autoimmune Disease Drug Product Image Figure 3. Global Autoimmune Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Autoimmune Disease Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Autoimmune Disease Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Autoimmune Disease Drug Market Share by Region (2021-2032) Figure 7. North America Autoimmune Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Autoimmune Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Autoimmune Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. NSAIDs Image Figure 13. Global NSAIDs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Interferons Image Figure 15. Global Interferons Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Antihyperglycemics Image Figure 17. Global Antihyperglycemics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Anti-Inflammatory Image Figure 19. Global Anti-Inflammatory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Autoimmune Disease Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Autoimmune Disease Drug Market Share by Type 2025 VS 2032 Figure 24. North America Autoimmune Disease Drug Market Size Share by Type (2021-2032) Figure 25. Europe Autoimmune Disease Drug Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Autoimmune Disease Drug Market Size Share by Type (2021-2032) Figure 27. Latin America Autoimmune Disease Drug Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Autoimmune Disease Drug Market Size Share by Type (2021-2032) Figure 29. Psoriasis Image Figure 30. Global Psoriasis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Inflammatory Bowel Disease Image Figure 32. Global Inflammatory Bowel Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Rheumatoid Arthritis Image Figure 34. Global Rheumatoid Arthritis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Lupus Image Figure 36. Global Lupus Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Multiple Sclerosis Image Figure 38. Global Multiple Sclerosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Type 1 Diabetes Image Figure 40. Global Type 1 Diabetes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Others Image Figure 42. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Global Autoimmune Disease Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Autoimmune Disease Drug Market Share by Application 2025 VS 2032 Figure 45. North America Autoimmune Disease Drug Market Size Share by Application (2021-2032) Figure 46. Europe Autoimmune Disease Drug Market Size Share by Application (2021-2032) Figure 47. Asia-Pacific Autoimmune Disease Drug Market Size Share by Application (2021-2032) Figure 48. Latin America Autoimmune Disease Drug Market Size Share by Application (2021-2032) Figure 49. Middle East and Africa Autoimmune Disease Drug Market Size Share by Application (2021-2032) Figure 50. Global Top 5 and 10 Autoimmune Disease Drug Players Market Share by Revenue in 2025 Figure 51. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 52. North America Autoimmune Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. North America Autoimmune Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. North America Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 55. Europe Autoimmune Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Autoimmune Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 58. Asia-Pacific Autoimmune Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Asia-Pacific Autoimmune Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 61. Latin America Autoimmune Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Autoimmune Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 64. Middle East & Africa Autoimmune Disease Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Middle East & Africa Autoimmune Disease Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 66. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2021-2032) Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Interferons
  • Antihyperglycemics
  • Anti-Inflammatory
  • Others
Applications
  • Psoriasis
  • Inflammatory Bowel Disease
  • Rheumatoid Arthritis
  • Lupus
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Others
Companies covered
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Amgen
  • AbbVie
  • Bristol-Myers Squibb
  • Biogen
  • AstraZeneca plc
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Autoimmune Disease Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Autoimmune Disease Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Autoimmune Disease Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Autoimmune Disease Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Autoimmune Disease Drug Market Size (2021-2032)
  8. 1.5.1 North America Autoimmune Disease Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Autoimmune Disease Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Autoimmune Disease Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate (2021-2032)
2 Autoimmune Disease Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 NSAIDs
  3. 2.1.2 Interferons
  4. 2.1.3 Antihyperglycemics
  5. 2.1.4 Anti-Inflammatory
  6. 2.1.5 Others
  7. 2.2 Global Autoimmune Disease Drug Market Size by Type
  8. 2.2.1 Global Autoimmune Disease Drug Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Autoimmune Disease Drug Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Autoimmune Disease Drug Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Autoimmune Disease Drug Market Size by Regions
  12. 2.3.1 North America Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Autoimmune Disease Drug Market Size Breakdown by Type (2021-2026)
3 Autoimmune Disease Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Psoriasis
  3. 3.1.2 Inflammatory Bowel Disease
  4. 3.1.3 Rheumatoid Arthritis
  5. 3.1.4 Lupus
  6. 3.1.5 Multiple Sclerosis
  7. 3.1.6 Type 1 Diabetes
  8. 3.1.7 Others
  9. 3.2 Global Autoimmune Disease Drug Market Size by Application
  10. 3.2.1 Global Autoimmune Disease Drug Market Size Overview by Application (2021-2032)
  11. 3.2.2 Global Autoimmune Disease Drug Historic Market Size Review by Application (2021-2026)
  12. 3.2.3 Global Autoimmune Disease Drug Market Size Forecasted by Application (2027-2032)
  13. 3.3 Global Autoimmune Disease Drug Market Size by Regions
  14. 3.3.1 North America Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.2 Europe Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026)
  16. 3.3.3 Asia-Pacific Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026)
  17. 3.3.4 South America Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026)
  18. 3.3.5 Middle East and Africa Autoimmune Disease Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Autoimmune Disease Drug Industry Trends
  2. 4.2 Autoimmune Disease Drug Industry Drivers
  3. 4.3 Autoimmune Disease Drug Industry Opportunities and Challenges
  4. 4.4 Autoimmune Disease Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Autoimmune Disease Drug Revenue (2021-2026)
  2. 5.2 Global Autoimmune Disease Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Autoimmune Disease Drug Key Company Headquarters & Area Served
  4. 5.4 Global Autoimmune Disease Drug Company, Product Type & Application
  5. 5.5 Global Autoimmune Disease Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Autoimmune Disease Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Autoimmune Disease Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Autoimmune Disease Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Roche Autoimmune Disease Drug Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Autoimmune Disease Drug Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Autoimmune Disease Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Autoimmune Disease Drug Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Autoimmune Disease Drug Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Autoimmune Disease Drug Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Bristol-Myers Squibb
  38. 6.7.1 Bristol-Myers Squibb Company Information
  39. 6.7.2 Bristol-Myers Squibb Business Overview
  40. 6.7.3 Bristol-Myers Squibb Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Autoimmune Disease Drug Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biogen Autoimmune Disease Drug Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 AstraZeneca plc
  50. 6.9.1 AstraZeneca plc Company Information
  51. 6.9.2 AstraZeneca plc Business Overview
  52. 6.9.3 AstraZeneca plc Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca plc Autoimmune Disease Drug Product Portfolio
  54. 6.9.5 AstraZeneca plc Recent Developments
  55. 6.10 Abbott Laboratories
  56. 6.10.1 Abbott Laboratories Company Information
  57. 6.10.2 Abbott Laboratories Business Overview
  58. 6.10.3 Abbott Laboratories Autoimmune Disease Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Laboratories Autoimmune Disease Drug Product Portfolio
  60. 6.10.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Autoimmune Disease Drug Market Size by Country (2021-2026)
  3. 7.3 North America Autoimmune Disease Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Autoimmune Disease Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Autoimmune Disease Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Autoimmune Disease Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Autoimmune Disease Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Autoimmune Disease Drug Market Size by Country (2021-2026)
  3. 10.3 South America Autoimmune Disease Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Autoimmune Disease Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst